-
Ikhithi yokubona umhlaza weUrothelial yamkelwa...
Ebutsheni bukaMeyi ka-2023, i-TAGMe DNA Methylation Detection Kit(qPCR) ye-Urothelial Cancer ephuhliswe ngokuzimeleyo yi-Shanghai Epiprobe Biotechnology Co., Ltd, ifumene “Ukutyunjwa kwesiXhobo esiNgqongileyo” kwi-US FDA.Inkqubo yeZixhobo zokuPhumelela kwe-FDA ijolise ekuqinisekiseni ukukhuthaza...Funda ngokugqithisileyo -
I-TAGMe DNA Methylation Detection Kits (qPCR) ye...
Isisombululo somhlaza we-endometrial, ukuphelisa umhlaza kwinqanaba lezilonda ze-precancerous.Umhlaza we-Endometrial ngomnye weyona ntlaza mithathu iyingozi kwi-gynecology.Umhlaza we-Endometrial yenye yezona zinto zixhaphakileyo zomhlaza onobungozi kwinkqubo yokuzala yabasetyhini, ngokwenqanaba ...Funda ngokugqithisileyo -
Baidu Health kunye Epiprobe ngentsebenziswano phambili...
Oct. 30, 2022, Baidu Health Internet Hospital (esibizwa ngokuba yi "Baidu Health") kunye ne-Shanghai Epiprobe Biotechnology Co., Ltd. (ebizwa ngokuba yi "Epiprobe") ibhengeze intsebenziswano yeqhinga lokwazisa ukujongwa kwangaphambili kwe-pan-cancer kwiklinikhi kunye ngokubanzi. amajelo ezempilo ngexesha...Funda ngokugqithisileyo -
Epiprobe's ezintathu zomhlaza methylation ukubhaqwa k...
NgoMeyi 8, 2022, i-Epiprobe yabhengeza ukuba iphuhlise ngokuzimeleyo iikhithi zokubona umhlaza we-methylation: TAGMe DNA Methylation Detection Kits (qPCR) for Cervical Cancer, TAGMe DNA Methylation Detection Kits (qPCR) for End...Funda ngokugqithisileyo -
I-Epiprobe igqityiwe phantse i-RMB 100 yezigidi zeSe...
Kutshanje, Shanghai Epiprobe Biotechnology Co., Ltd. (jonga njenge "Epiprobe") ubhengeze ukuba ugqibe phantse RMB 100 yezigidi kwi-Series B financing, nto leyo ityalwe ngokudibeneyo yinkunzi yemizi-mveliso, iqonga lotyalo-mali karhulumente...Funda ngokugqithisileyo
